Frontiers in Immunology (Jul 2025)

Uncovering hidden immune defects in childhood granulomatous disorders: a case report

  • Walter Maria Sarli,
  • Walter Maria Sarli,
  • Francesca Quaranta,
  • Clementina Canessa,
  • Lorenzo Lodi,
  • Laura Pisano,
  • Anna Maria Buccoliero,
  • Teresa Oranges,
  • Elena Sieni,
  • Gabriele Simonini,
  • Gabriele Simonini,
  • Luca Bartolini,
  • Luca Bartolini,
  • Elisabetta Venturini,
  • Luisa Galli,
  • Luisa Galli,
  • Chiara Azzari,
  • Chiara Azzari,
  • Silvia Ricci,
  • Silvia Ricci

DOI
https://doi.org/10.3389/fimmu.2025.1634661
Journal volume & issue
Vol. 16

Abstract

Read online

Granulomatous diseases in childhood present a complex diagnostic landscape, particularly when histological and clinical findings overlap with those of systemic inflammatory or histiocytic disorders. A subset of these conditions may represent the clinical onset of inborn errors of immunity (IEI), such as Mendelian Susceptibility to Mycobacterial Disease (MSMD), where atypical or sterile granulomas may obscure the underlying infectious or genetic etiology. Recognition of IEI behind granulomatous diseases can radically alter patient’s prognosis and therapeutic management. This report describes the case of a 11-years-old with an initial diagnosis of Rosai-Dorfman disease based on clinical and and histological findings. Following relapse after steroid tapering the diagnosis was revised to sarcoidosis, supported by non-caseating granulomas and compatible laboratory findings. Only after cultures from biopsy specimens revealed Mycobacterium avium complex (MAC), immunological investigations were undertaken, revealing a STAT1 dominant negative deficiency, consistent with MSMD. This report underscores the need of considering IEI in pediatric patients presenting with granulomatous inflammation, especially when clinical course is atypical or refractory to standard immunosuppressive therapies. Early microbiological and immunogenetic assessment is essential to avoid diagnostic delay, prevent inappropriate treatment, and guide targeted antimicrobial therapy.

Keywords